D-133
NDC 58264-0139, Calcium fluoride, Silicon dioxide, Tribasic calcium phosphate, Calcium sulfate anhydrous, Ferrosoferric phosphate, Potassium chloride, Dibasic potassium phosphate, Potassium sulfate, Magnesium phosphate, dibasic trihydrate, Sodium phosphate, dibasic, heptahydrate, Sodium chloride, and Sodium sulfate, solution, from DNA Labs, Inc..
- Product NDC
- 58264-0139
- Status
- Listed
- Labeler
- DNA Labs, Inc.
- Dosage form
- SOLUTION
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CALCIUM FLUORIDE8 [hp_X]/mL
- SILICON DIOXIDE8 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE6 [hp_X]/mL
- CALCIUM SULFATE ANHYDROUS6 [hp_X]/mL
- FERROSOFERRIC PHOSPHATE6 [hp_X]/mL
- POTASSIUM CHLORIDE6 [hp_X]/mL
- DIBASIC POTASSIUM PHOSPHATE6 [hp_X]/mL
- POTASSIUM SULFATE6 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE6 [hp_X]/mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE6 [hp_X]/mL
- SODIUM CHLORIDE6 [hp_X]/mL
- SODIUM SULFATE6 [hp_X]/mL
Pharmacologic classes
Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58264-0139-1 | 58264013901 | 29.57 mL in 1 BOTTLE, GLASS (58264-0139-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58264-0139 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58264-0139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58264-0139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.